Page 63 - TD-2-1

Tumor Discovery LCP2 regulates melanoma progression

regulatory domains of IRF-5 control activation, cellular 37. Pimenta EM, De S, Weiss R, et al., 2015, IRF5 is a novel
localization, and induction of chemokines that mediate regulator of CXCL13 expression in breast cancer that
recruitment of T lymphocytes. Mol Cell Biol, 22(16): regulates CXCR5(+) B-and T-cell trafficking to tumor
5721–5740. conditioned media. Immunol Cell Biol, 93(5): 486–499.
https://doi.org/1128/MCB.22.16.5721-5740.2002 https://doi.org/10.1038/icb.2014.110
36. Kaur A, Lee LH, Chow SC, et al., 2018, IRF5-mediated 38. Takaoka A, Yanai H, Kondo S, et al., 2005, Integral role of
immune responses and its implications in immunological IRF-5 in the gene induction programme activated by Toll-
disorders. Int Rev Immunol, 37(5): 229–248. like receptors. Nature, 434(7030): 243–249.
https://doi.org/10.1080/08830185.2018.146962 https://doi.org/10.1038/nature03308

Volume 2 Issue 1 (2023) 13 https://doi.org/10.36922/td.308